Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linden Bioscience, formerly known as Linden Technologies, is a biotechnology company specializing in the development and commercialization of advanced tools for molecular biology research. The company's primary focus is on the stabilization and purification of nucleic acids, particularly RNA and DNA, from various biological samples. Their proprietary technologies are designed to preserve the integrity of genetic material during collection, transport, and storage, which is critical for accurate downstream analysis in genomics and transcriptomics. Linden Bioscience provides a range of reagents and kits that are utilized by academic researchers, clinical laboratories, and pharmaceutical companies worldwide. By improving sample quality, the company supports advancements in disease research, diagnostics, and drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linden Technologies.